PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6257107

Endogenous hyperinsulinism.

D L Fowler·W G Wood·P G Koontz
View original source ↗Export metadata ↓

Abstract

Endogenous insulin excess as a cause of hypoglycemia was described soon after the epic discovery of insulin in 1921. Rosco Graham removed an insulinoma and cured a patient's hypoglycemia in 1929. Adenomatosis of the islet cells as a cause of hypoglycemia was described in 1944 by Frantz, who advocated subtotal pancreatectomy for this disorder. Whipple's triad of 1. symptoms precipitated by fasting with 2. associated blood sugars of 50 mg.% or less and 3. relief of symptoms by glucose administration, is the classic description of the symptom complex of hyperinsulinism. Currently the opportunity for accurate diagnosis of hyperinsulinism has been enhanced by the availability of serum insulin radioimmunoassay (IRI). Nonetheless, delay in diagnosis with potentially tragic consequences is still common and this prompted a review of the clinical material at St. Luke's Hospital. Nine cases of organic hyperinsulinism were diagnosed between 1965 abd 1979 and form the basis of this report.

Explore related subjects

AdenomaAdenoma, Islet CellAdultAgedFemaleHumansHyperinsulinismHyperplasiaIslets of LangerhansMaleMiddle AgedPancreatic NeoplasmsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D L Fowler, W G Wood, P G Koontz. 1980. Endogenous hyperinsulinism.. https://pubmed.ncbi.nlm.nih.gov/6257107/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2009

HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.

The high mobility group As (HMGAs) belong to a family of nonhistone nuclear proteins that orchestrate the assembly of nucleoprotein complexes. Through a complex network of protein-DNA and protein-protein interaction, they play important roles in gene transcription, recombination, and chromatin structure. This protein family is involved, through different mechanisms, in both benign and malignant neoplasias. We have recently reported that transgenic mice carrying the Hmga1 or Hmga2 genes under transcriptional control of the cytomegalovirus promoter develop pituitary adenomas secreting prolactin and growth hormone. We have shown that the mechanism of the HMGA2-induced pituitary adenoma is based on the increased E2F1 activity. The expression profile of mouse normal pituitary glands and adenomas induced in HMGA transgenic mice revealed an increased expression of the ccnb2 gene, coding for the cyclin B2 protein, in the neoplastic tissues compared with the normal pituitary gland. Here, we show, by electrophoretic mobility shift assay and chromatin immunoprecipitation, a direct binding of HMGA proteins to the promoter of ccnb2 gene, whereas luciferase assays showed that HMGAs are able to up-regulate ccnb2 promoter activity. Finally, we report an increased CCNB2 expression in human pituitary adenomas of different histotypes that is directly correlated with HMGA1 and HMGA2 expression. Because cyclin B2 is involved in the regulation of the cell cycle, these results taken together indicate that HMGA-induced cyclin B2 overexpression gives an important contribution to experimental and human pituitary tumorigenesis.

Adenoma↗
PubMed1999

Hypermethylation of the MYF-3 gene in colorectal cancers: associations with pathological features and with microsatellite instability.

Myf-3 is the human homologue of the murine Myo-D1 gene involved in muscle-cell differentiation. Using Southern blot analysis, we examined methylation of Myf-3 in histologically normal colonic mucosae, adenomas and carcinomas from a large series of patients with primary colorectal cancer. Hypermethylation of this gene in comparison with normal mucosa was observed in 88% of adenomas and in 99% of carcinomas. The pattern of Myf-3 methylation was similar in different areas of the same tumour, suggesting that methylation imbalances occur before the bulk of clonal-cell expansion. Significantly increased levels of Myf-3 methylation were observed in tumours which were more invasive, located in the proximal colon or from older patients. Patients whose tumours had extensive methylation showed a trend for shortened survival, though this was probably related to their being more invasive. Extensive methylation was significantly more frequent in tumours with microsatellite instability. Further work is required to determine whether the hypermethylation of Myf-3 observed in colorectal cancers is a specific alteration with functional significance or whether it reflects non-specific methylation imbalances occurring early during tumorigenesis.

Adenoma↗